To cite QIAGEN OmicSoft products (software and Lands), the citation should contain the name of the QIAGEN OmicSoft product (QIAGEN OmicSoft Studio, QIAGEN OmicSoft Suite, QIAGEN OncoLand, etc.) used, the version number of software and/or the release date or version for Land data..
What are the advantages of bioinformatics tools?
Benefits of Bioinformatics With the vast amount of data that can now be stored and analyzed, bioinformatics is helping doctors to more accurately diagnose and treat diseases. By analyzing a patient's DNA, doctors can better understand which disease they are dealing with and how to best treat it..
What is CLC software?
CLC Genomics Workbench is software for analyzing and visualizing next generation sequencing data. Its functionality includes de novo assembly of Sanger, 454, Illumina Genome Analyzer and SOLiD data and also de novo assembly from a combination of these platforms..
What is Qiagen software?
QIAGEN CLC Genomics Workbench is a powerful solution that works for everyone, no matter the workflow. Cutting-edge technology and unique features and algorithms widely used by scientific leaders in industry and academia make it easy to overcome challenges associated with data analysis..
Where is Qiagen digital insights?
QIAGEN Digital Insights Redwood City CA..
CLC Genomics Workbench is software for analyzing and visualizing next generation sequencing data. Its functionality includes de novo assembly of Sanger, 454, Illumina Genome Analyzer and SOLiD data and also de novo assembly from a combination of these platforms.
QIAGEN Digital Insights Redwood City CA.
To cite QIAGEN OmicSoft products (software and Lands), the citation should contain the name of the QIAGEN OmicSoft product (QIAGEN OmicSoft Studio, QIAGEN OmicSoft Suite, QIAGEN OncoLand, etc.) used, the version number of software and/or the release date or version for Land data.
QIAGEN is the recognized leader in bioinformatics solutions. We bring forth a track record of over 20 years and bioinformatics products built from best-in-class bioinformatics companies, with a deep customer base and market knowledge.
Expert-curated bioinformatics software for advancing genomic and clinical knowledge to make actionable insights from basic research to patient care!Products OverviewCLC GenomicsDiscovery Insights PortfolioProduct Login
What is my QIAGEN?
My QIAGEN makes managing your account and orders easier than ever. Whether you’d like to quickly check your order status or reorder, download free resources or simply get support – My QIAGEN is at your service.
What is QIAGEN's augmented molecular intelligence (AmI) knowledge base?
With an unrivalled, superior quality knowledge base powered by augmented molecular intelligence (AMI) and a comprehensive portfolio of bioinformatic software and services, we empower you to put science into meaningful action The content core of our portfolio, the QIAGEN Knowledge Base, is powered by augmented molecular intelligence (AMI).
What makes QIAGEN bioinformatics services a good company?
The QIAGEN Bioinformatics Services team is highly organized, diligent, rigorous and thorough. They put quality first and are very collaborative. They have the statistical expertise and agility in communication to solve our problems. They are open to feedback, and easily adapt to solving new problems when they arise.
Who is QIAGEN Digital Insights?
QIAGEN Digital Insights is the leading provider of genomic and clinical knowledge, analysis and interpretation tools and bioinformatics products for scientists and clinicians. QIAGEN is the recognized leader in bioinformatics solutions.
Bioinformatics qiagen
German biotechnology company
QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. European, American, and Asian regional headquarters are located in respectively Hilden, Germany; Germantown, Maryland United States; and Shanghai, China. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer(CEO). The main operative headquarters are located in Hilden, Germany.
Biotechnology software company
QIAGEN Silicon Valley is a company based in Redwood City, California, USA, that develops software to analyze complex biological systems. QIAGEN Silicon Valley's first product, IPA, was introduced in 2003, and is used to help researchers analyze omics data and model biological systems. The software has been cited in thousands of scientific molecular biology publications and is one of several tools for systems biology researchers and bioinformaticians in drug discovery and institutional research.
QIAGEN is a provider of sample and assay technologies
German biotechnology company
QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N. V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. European, American, and Asian regional headquarters are located in respectively Hilden, Germany; Germantown, Maryland United States; and Shanghai, China. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer(CEO). The main operative headquarters are located in Hilden, Germany.
Biotechnology software company
QIAGEN Silicon Valley is a company based in Redwood City, California, USA, that develops software to analyze complex biological systems. QIAGEN Silicon Valley's first product, IPA, was introduced in 2003, and is used to help researchers analyze omics data and model biological systems. The software has been cited in thousands of scientific molecular biology publications and is one of several tools for systems biology researchers and bioinformaticians in drug discovery and institutional research.
